These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37280463)

  • 21. Patient-reported perceptions of brexanolone in the treatment of postpartum depression: A qualitative analysis.
    Salwan A; Maroney M; Tremayne L
    Ment Health Clin; 2022 Dec; 12(6):342-349. PubMed ID: 36644587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.
    Meltzer-Brody S; Colquhoun H; Riesenberg R; Epperson CN; Deligiannidis KM; Rubinow DR; Li H; Sankoh AJ; Clemson C; Schacterle A; Jonas J; Kanes S
    Lancet; 2018 Sep; 392(10152):1058-1070. PubMed ID: 30177236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance.
    Voth M; Rosenberg M; Breuer J
    Invest Radiol; 2011 Nov; 46(11):663-71. PubMed ID: 21623211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of a Hospital-based Brexanolone Program.
    Howard MM; Diaz Z; Battle CL
    J Psychiatr Pract; 2022 Sep; 28(5):404-408. PubMed ID: 36074110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Brexanolone for Postpartum Depression Must Account for Lactation.
    Rosen-Carole C; Ito S
    Matern Child Health J; 2021 Jul; 25(7):1007-1009. PubMed ID: 34019187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
    Jara M; Aquilina T; Aupperle P; Rabinowicz AL
    Drug Healthc Patient Saf; 2015; 7():169-74. PubMed ID: 26719727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy.
    Reddy DS; Mbilinyi RH; Estes E
    Psychopharmacology (Berl); 2023 Sep; 240(9):1841-1863. PubMed ID: 37566239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brexanolone Is the First Drug Specifically for Postpartum Depression.
    Fantasia HC
    Nurs Womens Health; 2019 Oct; 23(5):450-454. PubMed ID: 31445988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
    Kanes S; Colquhoun H; Gunduz-Bruce H; Raines S; Arnold R; Schacterle A; Doherty J; Epperson CN; Deligiannidis KM; Riesenberg R; Hoffmann E; Rubinow D; Jonas J; Paul S; Meltzer-Brody S
    Lancet; 2017 Jul; 390(10093):480-489. PubMed ID: 28619476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
    Kanes SJ; Colquhoun H; Doherty J; Raines S; Hoffmann E; Rubinow DR; Meltzer-Brody S
    Hum Psychopharmacol; 2017 Mar; 32(2):. PubMed ID: 28370307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways.
    Balan I; Patterson R; Boero G; Krohn H; O'Buckley TK; Meltzer-Brody S; Morrow AL
    EBioMedicine; 2023 Mar; 89():104473. PubMed ID: 36801618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brexanolone Treatment in a Real-World Patient Population: A Case Series and Pilot Feasibility Study of Precision Neuroimaging.
    Guard M; Labonte AK; Mendoza M; Myers MJ; Duncan M; Drysdale AT; Mukherji E; Rahman T; Tandon M; Kelly JC; Cooke E; Rogers CE; Lenze S; Sylvester CM
    J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):240-249. PubMed ID: 38551454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products.
    Rollman JE; Heyward J; Olson L; Lurie P; Sharfstein J; Alexander GC
    JAMA; 2019 Feb; 321(7):676-685. PubMed ID: 30778596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data.
    Dodick DW; Tepper SJ; Ailani J; Pannacciulli N; Navetta MS; Loop B; Zhang F; Khodavirdi AC; Mann A; Abdrabboh A; Kalim J
    Headache; 2021 Oct; 61(9):1411-1420. PubMed ID: 34591982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating brexanolone for the treatment of postpartum depression.
    Payne JL
    Expert Opin Pharmacother; 2021 Jun; 22(8):959-964. PubMed ID: 33645386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System.
    Marwitz K; Jones SC; Kortepeter CM; Dal Pan GJ; Muñoz MA
    Drug Saf; 2020 May; 43(5):457-465. PubMed ID: 31981082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating postpartum depression with brexanolone.
    Burval J; Kerns R; Reed K
    Nursing; 2020 May; 50(5):48-53. PubMed ID: 32332506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose.
    Wald J; Henningsson A; Hanze E; Hoffmann E; Li H; Colquhoun H; Deligiannidis KM
    Clin Pharmacokinet; 2022 Sep; 61(9):1307-1319. PubMed ID: 35869362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
    Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
    Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.